ASCO Annual Meeting 2026: Key Clinical Trial Updates in Gynecologic Oncology
Authors:
- Marina Acevedo Zarzar MeloMMMarina Acevedo Zarzar Melo
- Jéssica Monteiro VasconcellosJVJéssica Monteiro Vasconcellos
- Mariana Carvalho GouveiaMGMariana Carvalho Gouveia
- Letícia Vecchi LeisLLLetícia Vecchi Leis
- Aniceto Lopes da Silva NetoANAniceto Lopes da Silva Neto
- Juliana Mandarano de MattosJMJuliana Mandarano de Mattos
- Mariana ScarantiMSMariana Scaranti
- 16 June 2026
- journal article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 36 (8) , 104813
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): a phase 3 randomised controlled trialThe Lancet, 2026
- Beyond resistance: redefining the therapeutic landscape of platinum-resistant ovarian cancerInternational Journal of Gynecological Cancer, 2025
- Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trialThe Lancet, 2025
- Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trialThe Lancet Oncology, 2024
- Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin–paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trialAnnals of Oncology, 2024
- MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapyAnnals of Oncology, 2024
- Immunohistochemical expression of PRAME in 485 cases of epithelial tubo-ovarian tumorsVirchows Archiv, 2023
- Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trialEuropean Journal of Cancer, 2020
- Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumorsGynecologic Oncology, 2017
- Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trialThe Lancet, 2015